XML 26 R16.htm IDEA: XBRL DOCUMENT

Consortium Agreement	6 Months Ended
Consortium Agreement	Jun. 30, 2022
Pledged Financial Instruments, Not Separately Reported, Securities, by Type of Agreement [Abstract]
Consortium Agreement	Consortium Agreement The Company has entered into consortium agreements with counterparties to collaborate on development of a process to commercialize bio-based, decarbonizing materials for application on an industrial scale at a competitive price. The agreements expire once performance of the research and development program has been completed. At the time the consortium agreements were entered into, several of the counterparties were related parties (Note 11). In 2020, an additional counterparty, that is an unrelated party, was added to the consortium agreement. Under the consortium agreement which was recorded as other income, net in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss), the Company received $0.0 million during three months ended June 30, 2022 and 2021 and $0.0 million and $0.5 million during the six months ended June 30, 2022 and 2021, respectively.